Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 9 | 2025 | 874 | 2.280 |
Why?
|
| Anticonvulsants | 5 | 2022 | 381 | 1.960 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 224 | 1.890 |
Why?
|
| Epilepsy, Absence | 4 | 2018 | 31 | 1.610 |
Why?
|
| Electroencephalography | 10 | 2023 | 865 | 0.960 |
Why?
|
| Phenylenediamines | 2 | 2025 | 24 | 0.840 |
Why?
|
| Parvalbumins | 2 | 2022 | 35 | 0.810 |
Why?
|
| Neurology | 2 | 2022 | 107 | 0.790 |
Why?
|
| KCNQ2 Potassium Channel | 4 | 2025 | 41 | 0.780 |
Why?
|
| Seizures | 7 | 2023 | 872 | 0.780 |
Why?
|
| Cerebral Cortex | 5 | 2019 | 452 | 0.680 |
Why?
|
| Electrocorticography | 2 | 2019 | 69 | 0.640 |
Why?
|
| Bradycardia | 1 | 2019 | 61 | 0.630 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 91 | 0.610 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2021 | 206 | 0.610 |
Why?
|
| Educational Measurement | 1 | 2020 | 324 | 0.580 |
Why?
|
| Ethosuximide | 1 | 2017 | 14 | 0.570 |
Why?
|
| Brain Waves | 1 | 2017 | 47 | 0.540 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 88 | 0.520 |
Why?
|
| Gamma Rhythm | 1 | 2015 | 12 | 0.500 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2015 | 6 | 0.480 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 854 | 0.450 |
Why?
|
| Internship and Residency | 2 | 2022 | 1182 | 0.440 |
Why?
|
| Clinical Competence | 1 | 2020 | 1007 | 0.430 |
Why?
|
| Muscular Diseases | 1 | 2014 | 103 | 0.420 |
Why?
|
| Eyelids | 1 | 2014 | 119 | 0.420 |
Why?
|
| Thalamus | 1 | 2014 | 83 | 0.420 |
Why?
|
| Neural Pathways | 1 | 2014 | 266 | 0.380 |
Why?
|
| Interneurons | 4 | 2022 | 143 | 0.370 |
Why?
|
| Genotype | 1 | 2017 | 2565 | 0.370 |
Why?
|
| KCNQ3 Potassium Channel | 2 | 2023 | 19 | 0.370 |
Why?
|
| Models, Genetic | 1 | 2014 | 760 | 0.350 |
Why?
|
| Adult | 11 | 2023 | 29627 | 0.340 |
Why?
|
| Comorbidity | 2 | 2023 | 1534 | 0.290 |
Why?
|
| Calcium Channels | 3 | 2018 | 160 | 0.290 |
Why?
|
| Calcium Channels, N-Type | 2 | 2017 | 24 | 0.270 |
Why?
|
| Carbamates | 2 | 2025 | 60 | 0.250 |
Why?
|
| Animals | 13 | 2025 | 34230 | 0.230 |
Why?
|
| Brain | 5 | 2024 | 2998 | 0.230 |
Why?
|
| Humans | 23 | 2025 | 125186 | 0.230 |
Why?
|
| Lafora Disease | 1 | 2024 | 3 | 0.230 |
Why?
|
| Mice | 9 | 2025 | 17631 | 0.220 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 74 | 0.220 |
Why?
|
| Pyramidal Cells | 4 | 2025 | 171 | 0.210 |
Why?
|
| Brain Mapping | 2 | 2023 | 398 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 106 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 356 | 0.190 |
Why?
|
| Behavior, Animal | 1 | 2024 | 490 | 0.190 |
Why?
|
| Receptors, Nicotinic | 1 | 2022 | 154 | 0.190 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 557 | 0.180 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2021 | 55 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4404 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3573 | 0.170 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2019 | 8 | 0.170 |
Why?
|
| Glioma | 1 | 2024 | 492 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 377 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2025 | 1112 | 0.170 |
Why?
|
| Age of Onset | 2 | 2019 | 595 | 0.160 |
Why?
|
| Male | 12 | 2025 | 61523 | 0.160 |
Why?
|
| Female | 12 | 2025 | 66803 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1141 | 0.150 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4395 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 504 | 0.140 |
Why?
|
| Sclerosis | 1 | 2017 | 34 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2397 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 405 | 0.140 |
Why?
|
| Prevalence | 1 | 2023 | 2458 | 0.130 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 190 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3744 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2018 | 126 | 0.130 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 351 | 0.130 |
Why?
|
| Deep Brain Stimulation | 1 | 2021 | 411 | 0.130 |
Why?
|
| Ankyrins | 1 | 2016 | 95 | 0.130 |
Why?
|
| Beta Rhythm | 1 | 2015 | 22 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 781 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 1216 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2018 | 789 | 0.120 |
Why?
|
| Cognition | 1 | 2019 | 728 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2015 | 63 | 0.110 |
Why?
|
| Video Recording | 1 | 2015 | 183 | 0.110 |
Why?
|
| Homeostasis | 1 | 2018 | 703 | 0.110 |
Why?
|
| Cattle | 1 | 2015 | 568 | 0.110 |
Why?
|
| Aicardi Syndrome | 1 | 2014 | 15 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1172 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 784 | 0.110 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 24 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 262 | 0.110 |
Why?
|
| Psychotherapy, Brief | 1 | 2013 | 48 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 344 | 0.100 |
Why?
|
| Phenotype | 3 | 2019 | 4262 | 0.100 |
Why?
|
| Prognosis | 2 | 2024 | 4645 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2015 | 389 | 0.100 |
Why?
|
| Middle Aged | 5 | 2019 | 26928 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2015 | 978 | 0.100 |
Why?
|
| Spasms, Infantile | 1 | 2014 | 171 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16353 | 0.100 |
Why?
|
| Hippocampus | 1 | 2017 | 824 | 0.090 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 5 | 0.090 |
Why?
|
| Nystagmus, Pathologic | 1 | 2011 | 22 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 532 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1238 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1694 | 0.090 |
Why?
|
| Status Epilepticus | 1 | 2012 | 148 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 548 | 0.090 |
Why?
|
| Neurons | 2 | 2018 | 1931 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 444 | 0.090 |
Why?
|
| Global Health | 1 | 2015 | 564 | 0.090 |
Why?
|
| Mutation | 3 | 2024 | 5845 | 0.080 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2009 | 18 | 0.080 |
Why?
|
| JC Virus | 1 | 2009 | 30 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 287 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3425 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 9053 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2107 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 3091 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 691 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2024 | 17 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2024 | 48 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 118 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 2593 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 102 | 0.050 |
Why?
|
| Prosencephalon | 1 | 2023 | 39 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 214 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 19871 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 319 | 0.050 |
Why?
|
| Affect | 1 | 2023 | 158 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2023 | 157 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 397 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 280 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2022 | 71 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2025 | 300 | 0.050 |
Why?
|
| Emotions | 1 | 2023 | 356 | 0.040 |
Why?
|
| Artifacts | 1 | 2021 | 109 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 462 | 0.040 |
Why?
|
| Oocytes | 1 | 2022 | 298 | 0.040 |
Why?
|
| United States | 1 | 2015 | 10914 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 345 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 813 | 0.040 |
Why?
|
| Neuropil | 1 | 2018 | 10 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 2018 | 84 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 890 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 954 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 384 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1497 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 403 | 0.030 |
Why?
|
| Child | 3 | 2022 | 24418 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 38 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 352 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 798 | 0.030 |
Why?
|
| Spasm | 1 | 2014 | 49 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 79 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 306 | 0.030 |
Why?
|
| Biophysics | 1 | 2012 | 50 | 0.030 |
Why?
|
| Electrodes | 1 | 2012 | 99 | 0.030 |
Why?
|
| ELAV Proteins | 1 | 2011 | 14 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4817 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 458 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 652 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1689 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1699 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2637 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1460 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3157 | 0.020 |
Why?
|
| Melibiose | 1 | 2003 | 1 | 0.010 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2003 | 4 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Lac Repressors | 1 | 2003 | 15 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2003 | 52 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 45 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 14026 | 0.010 |
Why?
|
| Lactose | 1 | 2003 | 54 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 88 | 0.010 |
Why?
|
| Urea | 1 | 2003 | 231 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 399 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 767 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 834 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 304 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 19362 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12392 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 2048 | 0.010 |
Why?
|